CN108101952A - A kind of ginsenoside Re and the preparation method of Rd - Google Patents

A kind of ginsenoside Re and the preparation method of Rd Download PDF

Info

Publication number
CN108101952A
CN108101952A CN201810031942.4A CN201810031942A CN108101952A CN 108101952 A CN108101952 A CN 108101952A CN 201810031942 A CN201810031942 A CN 201810031942A CN 108101952 A CN108101952 A CN 108101952A
Authority
CN
China
Prior art keywords
ginsenoside
mobile phase
ethyl alcohol
water
mixed proportion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810031942.4A
Other languages
Chinese (zh)
Inventor
金薇
关文顺
罗会
徐亚男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Rongxin Drug R & D Co Ltd
Original Assignee
Liaoning Rongxin Drug R & D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Rongxin Drug R & D Co Ltd filed Critical Liaoning Rongxin Drug R & D Co Ltd
Priority to CN201810031942.4A priority Critical patent/CN108101952A/en
Publication of CN108101952A publication Critical patent/CN108101952A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005Glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention discloses the preparation methods of a kind of ginsenoside Re and Rd, are as follows:Step 1 is taken ginseng stem and leave general saponin and is isolated and purified using macroporous absorbent resin, washed, then eluted with ethanol water, collect eluent and concentrated and dried, and respectively obtains the part containing ginsenoside Re and containing ginsenoside Rd;Step 2 takes the part rich in ginsenoside Re and is dissolved in ethanol water, eluted, collects the eluent of ginsenoside Re, is recovered under reduced pressure, concentrate vacuum freeze drying obtains the freeze-dried powder of ginsenoside Re;Step 3 takes the part rich in ginsenoside Rd and is dissolved in ethanol water, eluted, collects the eluent of ginsenoside Rd, is recovered under reduced pressure, concentrate vacuum freeze drying obtains the freeze-dried powder of ginsenoside Rd.The preparation method step of the present invention is simple, easy to operate, greatly reduces production cost;The product yield and purity that the method for the present invention obtains are all higher.

Description

A kind of ginsenoside Re and the preparation method of Rd
Technical field
The present invention relates to medical extraction fields, the specifically preparation method of a kind of ginsenoside Re and Rd.
Background technology
Ginseng is herbaceos perennial, and happiness is shady and cool, be grown on hundreds of meters of height above sea level between 33 degree of -48 degree of north latitude with red Theropencedrymion or broad leaved and deciduous broad leaved hayashishita based on pine originate in Northeast China, Korea, South Korea, Japan, Russian east.Ginseng As excellent tonic product, ingredient is extremely complex, and physiological activity is mostly derived from ginsenoside.Ginsenoside extract (mainly into Part is Rg1、Rg2、Rg3、Rb1、Rb2、Rb3、Rh、Rh1、Rh2With Ro etc.) be many tcm products primary raw material, ginsenoside uses In treatment shock, coronary heart disease, arrhythmia cordis, anaemia, chronic obstructive pulmonary disease, hyperlipemia, diabetes, tumour, neurasthenia, Climacteric syndrome, immunologic hypofunction disease.It is also used as having bad physiques, middle-aged and elderly people keeps fit and healthy, physical labourer disappears Except fatigue, brain worker's intelligence development, the functional health-care food raw material for improving memory.Meanwhile different ginsenoside monomer With different physiological activity, the preparation of various saponin monomers is the important active ingredient of research ginseng, scientifically establishes drug mark Standard and valuable saponin(e is synthesized and the basis of chemical modification, is only separated ginsenoside monomer one by one, The physiological activity of each monomer is specified, can just be suited the remedy to the case, preferably utilizes ginseng resource.The country carries general ginsenoside at present The comparison taken is more, but extracts the relatively fewer of monomer, and technical difficulty is higher;And the method for current separation and Extraction ginsenoside monomer Heavy duty detergent liquid chromatography and silica gel column chromatography are mainly prepared, these methods are all unavoidably using substantial amounts of chloroform, first The organic solvents such as alcohol, acetonitrile, environmental pollution are very big;Obtained ginseng monomer purity is relatively low, it is difficult to meet drug and health products Production requirement.
The content of the invention
It is an object of the invention to provide the preparation method of a kind of ginsenoside Re and Rd, to solve in above-mentioned background technology The problem of proposition.
To achieve the above object, the present invention provides following technical solution:
A kind of ginsenoside Re and the preparation method of Rd, are as follows:
Step 1 is taken ginseng stem and leave general saponin and is isolated and purified using macroporous absorbent resin, washed and discard washing De- liquid, then eluted with ethanol water, collect eluent and concentrated and dried, respectively obtain containing ginsenoside Re and Part containing ginsenoside Rd;
Step 2 takes the part rich in ginsenoside Re and is dissolved in ethanol water, using preparative high-efficient liquid phase color Spectrometer, 10 μm of chromatographic columns of Me C18 20*250mm, Detection wavelength 203nm, flow velocity 13mL/min, sample introduction 10mL are washed De-, mobile phase A is ethyl alcohol, and Mobile phase B is water, and the gradient of elution is the mixed proportion in 0-35 minutes mobile phase As and Mobile phase B 32% A is remained, the mixed proportion of mobile phase A and Mobile phase B gradually increases the A for 100% in 35-35.1 minutes, The mixed proportion of mobile phase A and Mobile phase B remains 100% A in 35.1-50 minutes, collects the eluent of ginsenoside Re, Ethyl alcohol is recovered under reduced pressure, concentrate vacuum freeze drying obtains the freeze-dried powder of ginsenoside Re;
Step 3 takes the part rich in ginsenoside Rd and is dissolved in ethanol water, using preparative high-efficient liquid phase color Spectrometer, 10 μm of chromatographic columns of Me C18 20*250mm, Detection wavelength 203nm, flow velocity 13mL/min, sample introduction 10mL are washed De-, mobile phase A is ethyl alcohol, and Mobile phase B is water, and the gradient of elution is the mixed proportion in 0-40 minutes mobile phase As and Mobile phase B The A for 35-60% is gradually increased, the mixed proportion of mobile phase A and Mobile phase B is gradually increased as 60- in 40-40.1 minutes 100% A, the mixed proportion of mobile phase A and Mobile phase B remains 100% A in 40.1-55 minutes, collects ginsenoside The eluent of Rd, is recovered under reduced pressure ethyl alcohol, and concentrate vacuum freeze drying obtains the freeze-dried powder of ginsenoside Rd.
As further embodiment of the present invention:It is carried out gen-seng haulms in step 1 before macroporous absorbent resin isolates and purifies Total saposins high purity water stirring and dissolving.
Compared with prior art, the beneficial effects of the invention are as follows:The preparation method step of the present invention is simple, easy to operate, It is economic and environment-friendly, using ginsenoside powder as raw material, cost is reduced from raw material, using second alcohol and water as solvent, is avoided Using have pollution to environment methanol, acetonitrile, chloroform, acetone and other organic solvent, and ethyl alcohol carries out recycling in production process and follows Ring uses, and greatly reduces production cost;The product yield and purity that the method for the present invention obtains are all higher:Obtained monomer Purity reaches more than 85%, and monomer yield is more than 80%, far above current conventional method.
Specific embodiment
The technical solution of this patent is described in more detail With reference to embodiment.
Embodiment 1:
Take ginseng stem and leave general saponin, high purity water stirring and dissolving, upper D101 large pore resin absorption columns, successively with pure water, 20% Ethanol water, 60% ethanol water, anhydrous ethanol elution, eluent carries out ethyl alcohol recycling respectively.20% ethyl alcohol Eluent recovered ethyl alcohol obtains the crude product rich in ginsenoside Re, the 60% recovered second of ethanol eluate after freeze-drying Alcohol obtains the crude product rich in ginsenoside Rd after freeze-drying.
Embodiment 2:
Take ginseng stem and leave general saponin, high purity water stirring and dissolving, upper AB-8 large pore resin absorption columns, successively with pure water, 30% Ethanol water, 65% ethanol water, anhydrous ethanol elution, eluent carries out ethyl alcohol recycling respectively.30% ethyl alcohol Eluent recovered ethyl alcohol obtains the crude product rich in ginsenoside Re, the 65% recovered second of ethanol eluate after freeze-drying Alcohol obtains the crude product rich in ginsenoside Rd after freeze-drying.
Embodiment 3:
Take ginseng stem and leave general saponin, high purity water stirring and dissolving, upper HPD100 large pore resin absorption columns, successively with pure water, 30% ethanol water, 65% ethanol water, anhydrous ethanol elution, eluent carry out ethyl alcohol recycling respectively.30% The recovered ethyl alcohol of ethanol eluate, obtains the crude product rich in ginsenoside Re after freeze-drying, 65% ethanol eluate passes through back Ethyl alcohol is received, the crude product rich in ginsenoside Rd is obtained after freeze-drying.
Embodiment 4:
Take ginseng stem and leave general saponin, high purity water stirring and dissolving, upper HPD300 large pore resin absorption columns, successively with pure water, 20% ethanol water, 55% ethanol water, anhydrous ethanol elution, eluent carry out ethyl alcohol recycling respectively.20% The recovered ethyl alcohol of ethanol eluate, obtains the crude product rich in ginsenoside Re after freeze-drying, 55% ethanol eluate passes through back Ethyl alcohol is received, the crude product rich in ginsenoside Rd is obtained after freeze-drying.
Embodiment 5:
Take ginseng stem and leave general saponin, high purity water stirring and dissolving, upper ADS-7 large pore resin absorption columns, successively with pure water, 40% Ethanol water, 70% ethanol water, anhydrous ethanol elution, eluent carries out ethyl alcohol recycling respectively.40% ethyl alcohol Eluent recovered ethyl alcohol obtains the crude product rich in ginsenoside Re, the 70% recovered second of ethanol eluate after freeze-drying Alcohol obtains the crude product rich in ginsenoside Rd after freeze-drying.
Embodiment 6:
Take ginseng stem and leave general saponin, high purity water stirring and dissolving, upper HP20 large pore resin absorption columns, successively with pure water, 25% Ethanol water, 70% ethanol water, anhydrous ethanol elution, eluent carries out ethyl alcohol recycling respectively.25% ethyl alcohol Eluent recovered ethyl alcohol obtains the crude product rich in ginsenoside Re, the 70% recovered second of ethanol eluate after freeze-drying Alcohol obtains the crude product rich in ginsenoside Rd after freeze-drying.
The preparation extraction process of ginsenoside Re, implementation steps include:
The foregoing obtained crude product rich in ginsenoside Re is dissolved in 30% ethanol water, using the efficient liquid of preparative Chromatography, 10 μm of chromatographic columns of Me C18 20*250mm, Detection wavelength 203nm, flow velocity 13mL/min, sample introduction 10mL are pressed The mobile phase ratio of table 5 is eluted.
5 eluent gradient table of table
The eluent of ginsenoside Re is collected, ethyl alcohol is recovered under reduced pressure, ginsenoside is made in concentrate vacuum freeze drying The freeze-dried powder of Re.
The preparation extraction process of ginsenoside Rd, implementation steps include:
The foregoing obtained component rich in ginsenoside Rd is dissolved in 30% ethanol water, using the efficient liquid of preparative Chromatography, 10 μm of chromatographic columns of Me C18 20*250mm, Detection wavelength 203nm, flow velocity 13mL/min, sample introduction 10mL are pressed The gradient elution table of table 6 is eluted.
6 gradient elution table of table
The eluent of ginsenoside Rd is collected, ethyl alcohol is recovered under reduced pressure, ginsenoside Rd is made in concentrate vacuum freeze drying Freeze-dried powder
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned exemplary embodiment, Er Qie In the case of without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter From the point of view of which point, the present embodiments are to be considered as illustrative and not restrictive, and the scope of the present invention is by appended power Profit requirement rather than above description limit, it is intended that all by what is fallen within the meaning and scope of the equivalent requirements of the claims Variation is included within the present invention.
Moreover, it will be appreciated that although this specification is described in terms of embodiments, but not each embodiment is only wrapped Containing an independent technical solution, this description of the specification is merely for the sake of clarity, and those skilled in the art should Using specification as an entirety, the technical solutions in each embodiment can also be properly combined, forms those skilled in the art It is appreciated that other embodiment.

Claims (2)

1. a kind of ginsenoside Re and the preparation method of Rd, which is characterized in that be as follows:
Step 1 is taken ginseng stem and leave general saponin and is isolated and purified using macroporous absorbent resin, washed and discard water elution, It is eluted again with ethanol water, collect eluent and is concentrated and dried, respectively obtained containing ginsenoside Re and contained The part of ginsenoside Rd;
Step 2 takes the part rich in ginsenoside Re and is dissolved in ethanol water, using preparative high performance liquid chromatography instrument, 10 μm of chromatographic columns of Me C18 20*250mm, Detection wavelength 203nm, flow velocity 13mL/min, sample introduction 10mL are eluted, flowing Phase A is ethyl alcohol, and Mobile phase B is water, and the gradient of elution remains for the mixed proportion in 0-35 minutes mobile phase As and Mobile phase B 32% A, the mixed proportion of mobile phase A and Mobile phase B gradually increases the A for 100% in 35-35.1 minutes, in 35.1-50 The mixed proportion of mobile phase A and Mobile phase B remains 100% A in minute, collects the eluent of ginsenoside Re, depressurizes back Ethyl alcohol is received, concentrate vacuum freeze drying obtains the freeze-dried powder of ginsenoside Re;
Step 3 takes the part rich in ginsenoside Rd and is dissolved in ethanol water, using preparative high performance liquid chromatography instrument, 10 μm of chromatographic columns of Me C18 20*250mm, Detection wavelength 203nm, flow velocity 13mL/min, sample introduction 10mL are eluted, flowing Phase A is ethyl alcohol, and Mobile phase B is water, and the gradient of elution gradually increases for the mixed proportion in 0-40 minutes mobile phase As and Mobile phase B The A of 35-60% is added as, the mixed proportion of mobile phase A and Mobile phase B is gradually increased as 60-100%'s in 40-40.1 minutes A, the mixed proportion of mobile phase A and Mobile phase B remains 100% A in 40.1-55 minutes, collects washing for ginsenoside Rd De- liquid, is recovered under reduced pressure ethyl alcohol, concentrate vacuum freeze drying obtains the freeze-dried powder of ginsenoside Rd.
2. ginsenoside Re according to claim 1 and the preparation method of Rd, which is characterized in that carried out in the step 1 Macroporous absorbent resin isolate and purify before by ginseng stem and leave general saponin high purity water stirring and dissolving.
CN201810031942.4A 2018-01-12 2018-01-12 A kind of ginsenoside Re and the preparation method of Rd Pending CN108101952A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810031942.4A CN108101952A (en) 2018-01-12 2018-01-12 A kind of ginsenoside Re and the preparation method of Rd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810031942.4A CN108101952A (en) 2018-01-12 2018-01-12 A kind of ginsenoside Re and the preparation method of Rd

Publications (1)

Publication Number Publication Date
CN108101952A true CN108101952A (en) 2018-06-01

Family

ID=62218974

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810031942.4A Pending CN108101952A (en) 2018-01-12 2018-01-12 A kind of ginsenoside Re and the preparation method of Rd

Country Status (1)

Country Link
CN (1) CN108101952A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113004364A (en) * 2021-03-25 2021-06-22 杭州天草科技有限公司 Preparation method of high-purity ginsenoside Re
CN113831380A (en) * 2020-06-24 2021-12-24 山东新时代药业有限公司 Preparation process of ginsenoside Re and ginsenoside Rg1

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1869048A (en) * 2006-06-21 2006-11-29 海南亚洲制药有限公司 Method of extracting and separating F group ginseng saponin from ginseng leaf
CN1869055A (en) * 2006-06-21 2006-11-29 海南亚洲制药有限公司 Method of extracting and separating ginseng saponine monomer from ginseng leaf
CN101032535A (en) * 2006-12-22 2007-09-12 吉林人参研究院 Extracting purified ginsenoside from leaves of Panax quinquefolium and ginseng at the same time and the preparing method thereof
CN101575357A (en) * 2008-05-09 2009-11-11 澳门大学 Method for preparing notoginsenoside R1 and ginsenoside Rg1, Re, Rb1 and Rd
CN101829170A (en) * 2010-05-13 2010-09-15 北京中海康医药科技发展有限公司 Extract of panax notoginseng saponins and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1869048A (en) * 2006-06-21 2006-11-29 海南亚洲制药有限公司 Method of extracting and separating F group ginseng saponin from ginseng leaf
CN1869055A (en) * 2006-06-21 2006-11-29 海南亚洲制药有限公司 Method of extracting and separating ginseng saponine monomer from ginseng leaf
CN101032535A (en) * 2006-12-22 2007-09-12 吉林人参研究院 Extracting purified ginsenoside from leaves of Panax quinquefolium and ginseng at the same time and the preparing method thereof
CN101575357A (en) * 2008-05-09 2009-11-11 澳门大学 Method for preparing notoginsenoside R1 and ginsenoside Rg1, Re, Rb1 and Rd
CN101829170A (en) * 2010-05-13 2010-09-15 北京中海康医药科技发展有限公司 Extract of panax notoginseng saponins and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113831380A (en) * 2020-06-24 2021-12-24 山东新时代药业有限公司 Preparation process of ginsenoside Re and ginsenoside Rg1
CN113831380B (en) * 2020-06-24 2023-07-07 山东新时代药业有限公司 Preparation process of ginsenoside Re and Rg1
CN113004364A (en) * 2021-03-25 2021-06-22 杭州天草科技有限公司 Preparation method of high-purity ginsenoside Re

Similar Documents

Publication Publication Date Title
CN101260131A (en) Method for extracting iridoid active site and monomer from eucommia bark
CN107266400B (en) Method for extracting lactuca sativa bitter principle from chicory
CN105130759B (en) A kind of extracting method of Magnolia cortex P.E
CN102180938A (en) Method for preparing capilliposide
CN108101952A (en) A kind of ginsenoside Re and the preparation method of Rd
CN109879919B (en) Method for separating and preparing three flavonoid glycosides from spina date seeds
CN107098942A (en) A kind of method of kaempferia galamga glycosides in Subcritical Water Extraction radish leaves
CN103554209B (en) Method for preparing ginsenoside Rg1 from pseudo-ginseng
CN107903291A (en) A kind of chromone ketoside compounds and its methods and applications from windproof middle extraction
CN106045960B (en) A kind of method that Diphenylheptane class substance is extracted from galangal
CN106916162B (en) A kind of preparation method of jolkinolide B bulk pharmaceutical chemicals
CN105837546A (en) Method for separating and purifying alnustone, pinocembrin, cardamomin and alpinetin from alpinia katsumadai
CN103086967A (en) Alkaloid having type 1 skeleton in Nigellaglandulifera Freyn grass seeds, and its preparation method
CN110526890A (en) A method of dihydromyricetin is isolated and purified and identified from vine tea tissue
CN101974581A (en) Theaflavin extraction and purification method
CN106831936B (en) The method that tanshinone IIA and dihydrotanshinone I are prepared using middle high-pressure preparation liquid phase method
CN109293726A (en) Diol type ginsenoside extract and preparation method thereof
CN105294789B (en) A kind of preparation method of high-purity salidroside
CN107721857A (en) A kind of method that high-purity chlorogenic acid is prepared from Gynura procumbens (Lour.) Merr
CN104725449A (en) Paeoniflorin extracting method
CN107353296B (en) A method of extracting activated protein and eurycomanone from Tongkat Ali
US10435384B2 (en) Method for extracting herbacetin from plants of Rhodiola L
CN102078400B (en) Preparation method of extract of total triterpene acid of loquat leaf
CN101791335A (en) Total alkaloid mixture sourcing from Chinese medicina plant lotus plumule and extraction and preparation method thereof
CN111675741A (en) Separation method for simultaneously obtaining four kinds of epimedium rare flavone by using preparative liquid phase method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180601

RJ01 Rejection of invention patent application after publication